Booth Bruce (CIK 1451612) reported 222 SEC Form 4 insider transactions across 3 companies over the past 18 months (most recent 2026-07-02). Recent activity: Sell KYMR (5,549 shares), Sell KYMR (130 shares), Sell KYMR (19,419 shares), Sell KYMR (10,848 shares), Sell KYMR (7,968 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-02 | Kymera Therapeutics, Inc. (KYMR) | Director | Sell | 5,549 | $586,973 |
| 2026-07-02 | Kymera Therapeutics, Inc. (KYMR) | Director | Sell | 130 | $14,456 |
| 2026-07-02 | Kymera Therapeutics, Inc. (KYMR) | Director | Sell | 19,419 | $2.1M |
| 2026-07-02 | Kymera Therapeutics, Inc. (KYMR) | Director | Sell | 10,848 | $1.2M |
| 2026-07-02 | Kymera Therapeutics, Inc. (KYMR) | Director | Sell | 7,968 | $874,488 |
| 2026-07-02 | Kymera Therapeutics, Inc. (KYMR) | Director | Sell | 7,723 | $854,704 |
| 2026-07-02 | Kymera Therapeutics, Inc. (KYMR) | Director | Sell | 934 | $103,861 |
| 2026-07-02 | Kymera Therapeutics, Inc. (KYMR) | Director | Sell | 14,798 | $1.6M |
| 2026-07-02 | Kymera Therapeutics, Inc. (KYMR) | Director | Sell | 2,133 | $227,442 |
| 2026-07-02 | Kymera Therapeutics, Inc. (KYMR) | Director | Sell | 2,698 | $290,736 |
| 2026-07-02 | Kymera Therapeutics, Inc. (KYMR) | Director | Sell | 1,498 | $162,203 |
| 2026-07-02 | Kymera Therapeutics, Inc. (KYMR) | Director | Sell | 1,104 | $121,164 |
| 2026-07-02 | Kymera Therapeutics, Inc. (KYMR) | Director | Sell | 1,078 | $119,302 |
| 2026-07-02 | Kymera Therapeutics, Inc. (KYMR) | Director | Sell | 770 | $81,451 |
| 2026-06-30 | Kymera Therapeutics, Inc. (KYMR) | Director | Sell | 10,658 | $1.2M |
| 2026-06-30 | Kymera Therapeutics, Inc. (KYMR) | Director | Sell | 28,296 | $3.0M |
| 2026-06-30 | Kymera Therapeutics, Inc. (KYMR) | Director | Sell | 231,007 | $25.0M |
| 2026-06-30 | Kymera Therapeutics, Inc. (KYMR) | Director | Sell | 7,833 | $859,672 |
| 2026-06-30 | Kymera Therapeutics, Inc. (KYMR) | Director | Sell | 7,602 | $841,313 |
| 2026-06-30 | Kymera Therapeutics, Inc. (KYMR) | Director | Sell | 1,239 | $135,980 |
| 2026-06-30 | Kymera Therapeutics, Inc. (KYMR) | Director | Sell | 907 | $100,858 |
| 2026-06-30 | Kymera Therapeutics, Inc. (KYMR) | Director | Sell | 11,277 | $1.2M |
| 2026-06-30 | Kymera Therapeutics, Inc. (KYMR) | Director | Sell | 1,688 | $182,777 |
| 2026-06-30 | Kymera Therapeutics, Inc. (KYMR) | Director | Sell | 10,366 | $1.2M |
| 2026-06-30 | Kymera Therapeutics, Inc. (KYMR) | Director | Sell | 32,624 | $3.6M |
Source: SEC Form 4 filings · as of 2026-07-02